Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZMIZ2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | RBMY1D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | HELZ | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | LRRC14B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | PHF14 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GLRA1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CHST1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ATAD2B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CLUH | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | UBE2V1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |